CARLOS BUCHHAMMER: Open Payments
NPI 1992744015 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 42 payments from 16 companies in 2025. Trend: 2023 $1,630 · 2024 $1,386 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $262 |
| ABBVIE INC. | 6 | $107 |
| Collegium Pharmaceutical, Inc. | 3 | $68 |
| PFIZER INC. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Astellas Pharma US Inc | 3 | $57 |
| Amgen Inc. | 3 | $51 |
| Antares Pharma, Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: Ozempic, Belbuca, NURTEC ODT, Veozah, Wegovy, QULIPTA, UBRELVY, OTEZLA.
Industry payments across GA — which companies pay providers there.
